192 related articles for article (PubMed ID: 12029631)
21. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
23. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
24. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.
Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP
Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540
[TBL] [Abstract][Full Text] [Related]
26. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma.
Masaki T; Tokuda M; Ohnishi M; Watanabe S; Fujimura T; Miyamoto K; Itano T; Matsui H; Arima K; Shirai M; Maeba T; Sogawa K; Konishi R; Taniguchi K; Hatanaka Y; Hatase O; Nishioka M
Hepatology; 1996 Jul; 24(1):72-81. PubMed ID: 8707286
[TBL] [Abstract][Full Text] [Related]
27. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma.
Li XR; Ji F; Ouyang J; Wu W; Qian LY; Yang KY
Eur J Surg Oncol; 2006 Dec; 32(10):1130-4. PubMed ID: 16806792
[TBL] [Abstract][Full Text] [Related]
29. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
[TBL] [Abstract][Full Text] [Related]
30. 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis.
Zubaidah RM; Tan GS; Tan SB; Lim SG; Lin Q; Chung MC
Proteomics; 2008 Dec; 8(23-24):5086-96. PubMed ID: 19003864
[TBL] [Abstract][Full Text] [Related]
31. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
[TBL] [Abstract][Full Text] [Related]
32. Comparative proteomic and transcriptomic profiling of the human hepatocellular carcinoma.
Minagawa H; Honda M; Miyazaki K; Tabuse Y; Teramoto R; Yamashita T; Nishino R; Takatori H; Ueda T; Kamijo K; Kaneko S
Biochem Biophys Res Commun; 2008 Feb; 366(1):186-92. PubMed ID: 18060859
[TBL] [Abstract][Full Text] [Related]
33. Laser capture microdissection in comparative proteomic analysis of hepatocellular carcinoma.
Wang HY
Methods Cell Biol; 2007; 82():689-707. PubMed ID: 17586277
[TBL] [Abstract][Full Text] [Related]
34. Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus.
Kuramitsu Y; Harada T; Takashima M; Yokoyama Y; Hidaka I; Iizuka N; Toda T; Fujimoto M; Zhang X; Sakaida I; Okita K; Oka M; Nakamura K
Electrophoresis; 2006 Apr; 27(8):1651-8. PubMed ID: 16609938
[TBL] [Abstract][Full Text] [Related]
35. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
36. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
[TBL] [Abstract][Full Text] [Related]
37. The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice.
Cui F; Wang Y; Wang J; Wei K; Hu J; Liu F; Wang H; Zhao X; Zhang X; Yang X
Proteomics; 2006 Jan; 6(2):498-504. PubMed ID: 16317774
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of transient receptor potential vanilloid 2 expression in human hepatocellular carcinoma.
Liu G; Xie C; Sun F; Xu X; Yang Y; Zhang T; Deng Y; Wang D; Huang Z; Yang L; Huang S; Wang Q; Liu G; Zhong D; Miao X
Cancer Genet Cytogenet; 2010 Feb; 197(1):54-9. PubMed ID: 20113837
[TBL] [Abstract][Full Text] [Related]
39. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat.
Pascale RM; De Miglio MR; Muroni MR; Simile MM; Daino L; Seddaiu MA; Pusceddu S; Gaspa L; Calvisi D; Manenti G; Feo F
Hepatology; 1998 Feb; 27(2):452-61. PubMed ID: 9462644
[TBL] [Abstract][Full Text] [Related]
40. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.
Xu X; Wei X; Ling Q; Cheng J; Zhou B; Xie H; Zhou L; Zheng S
J Gastroenterol Hepatol; 2011 Dec; 26(12):1787-94. PubMed ID: 21649721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
